Astra Pharmaceutical Products

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company primarily operates in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal, metabolism, and respiratory & immunology. Formed through the 1999 merger of Sweden's Astra AB and the UK's Zeneca Group, it has a significant global footprint with major R&D centers in the UK, Sweden, and the US. Its portfolio includes blockbuster drugs such as Tagrisso, Farxiga, and Imfinzi, as well as a robust pipeline of biologics and small molecules. The company is also a leader in the development of antibody-drug conjugates and cell therapies through strategic acquisitions like Alexion and partnerships with Daiichi Sankyo.